Detalles de la búsqueda
1.
Improved nationwide survival of sarcoma patients with a network of reference centers.
Ann Oncol
; 35(4): 351-363, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38246351
2.
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)â.
Ann Oncol
; 32(4): 533-541, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33482247
3.
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial.
Ann Oncol
; 32(8): 1034-1044, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932507
4.
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations.
Ann Oncol
; 31(2): 289-294, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959346
5.
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.
Ann Oncol
; 31(11): 1506-1517, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32891793
6.
Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages.
Ann Oncol
; 30(8): 1381-1392, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31114846
7.
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.
Ann Oncol
; 30(5): 757-765, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30865223
8.
Surgery in reference centers improves survival of sarcoma patients: a nationwide study.
Ann Oncol
; 30(7): 1143-1153, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31081028
9.
Survival Benefit of the Surgical Management of Retroperitoneal Sarcoma in a Reference Center: A Nationwide Study of the French Sarcoma Group from the NetSarc Database.
Ann Surg Oncol
; 26(7): 2286-2293, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31065964
10.
Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
Int J Gynecol Cancer
; 29(4): 691-698, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30772825
11.
Why will there never be a randomized trial for NTRK-rearranged tumors?
Ann Oncol
; 34(7): 626-628, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068657
12.
The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.
Ann Oncol
; 29(2): 459-465, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29069276
13.
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.
Ann Oncol
; 29(3): 758-765, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29216400
14.
Improving at a nationwide level the management of patients with sarcomas with an expert network.
Ann Oncol
; 33(6): 659-661, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35219775
15.
Added therapeutic benefit regarding ESMO-MCBS and the French health technology assessment of drugs granted early access program.
Ann Oncol
; 33(5): 561-563, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35176459
16.
Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe.
Ann Oncol
; 33(11): 1200-1202, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35926814
17.
Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol.
Ann Oncol
; 28(11): 2773-2779, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28945826
18.
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Ann Oncol
; 28(12): 3000-3008, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28950372
19.
Improved survival using specialized multidisciplinary board in sarcoma patients.
Ann Oncol
; 28(11): 2852-2859, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29117335
20.
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database.
Ann Oncol
; 28(8): 1979-1987, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28838212